| |
| Today’s Top Story
New AAOS Annual Meeting Format to Debut this March in Las Vegas
The AAOS 2023 Annual Meeting features a reimagined meeting format with specialty society programs bookending the meeting on Tuesday and Saturday. This change will allow attendees to synchronize their experiences, with Academy education content topics aligning with the specialty society program schedule. AAOS Annual Meeting Committee Chair Matthew Provencher, MD, MBA, FAAOS, calls the move “the biggest change in the past 25 years to the AAOS meeting.” Registration is now open for the AAOS 2023 Annual Meeting, with early-bird rates available through Dec. 9.
Learn more and register… |
| |
|
|
|
| |
| In Other News
Retrospective Study Compares Outcomes of Aseptic Partial- and Full-component Revision TKA
The Journal of Arthroplasty published a retrospective study comparing the functional outcomes and rates of re-revision in patients undergoing partial and full revision total knee arthroplasty (rTKA). Patients were categorized as full rTKA (F-rTKA, n = 217) if femoral and tibial components were revised, and partial rTKA (P-rTKA, n = 76) if only one component was revised. P-rTKA patients had significantly shorter surgical time (109 minutes versus 141 minutes). At a mean follow-up of 4.2 years postsurgery, re-revision rates and visual analog scale pain and Knee Injury Osteoarthritis Scale scores were comparable between groups.
Read the abstract… |
| |
|
|
|
| |
| Study: Scalene Muscle Botulinum Toxin Injection with and without Rib Resection in Patients with Neurogenic Thoracic Outlet Syndrome
According to a retrospective study published in the Clinical Journal of Sports Medicine, scalene botulinum toxin injection (BTI) followed by first rib resection provided additional improvements over BTI alone in patients with neurogenic thoracic outlet syndrome. The outcome measurements were pain relief and Quick Disability of the Arm, Shoulder, and Hand (QuickDASH) score. Of the 77 patients, 77.9 percent reported subjective relief and improved QuickDASH scores after BTI. Thirty-one patients had persistent symptoms and proceeded with first rib resection. After BTI and surgery, 96.8 percent reported relief and had an average QuickDASH score improvement of 21.
Read the abstract… |
| |
|
|
|
| |
| Randomized Study: Nonoperative versus Operative Treatment for Displaced Finger Metacarpal Shaft Fractures
A randomized study published in The Journal of Bone & Joint Surgery investigated whether operative treatment is superior to nonoperative treatment for metacarpal shaft fractures. Overall, 42 patients were randomized to nonoperative treatment with unrestricted mobilization or operative treatment with screw fixation. The main outcomes were costs, metacarpal shortening, and complications. At one-year follow-up, the mean metacarpal shortening was 5.3 mm in the nonoperative group and 2.3 mm in the operative group. One complication occurred in the nonoperative group compared with four minor complications and three reoperations in the operative group. Costs were 2.8 times higher in the operative group.
Read the study… |
| |
|
|
|
| |
| Study: Aspirin as DVT Prophylaxis in Lumbar Canal Spinal Stenosis Surgery
Current Orthopaedic Practice published a double-blind parallel randomized clinical study assessing aspirin for the prevention of deep vein thrombosis (DVT) in patients undergoing lumbar spinal surgery. Forty-one patients were randomized to either the experimental group, which received 325 mg aspirin, or the control group. DVT occurrence and D-dimer levels were measured at baseline and two, six, and 12 weeks postsurgery. There were no cases of DVT in either group, and the mean duration of hospitalization was comparable. Baseline D-dimer levels were significantly higher in the aspirin group, but comparable between groups three months postoperatively.
Read the abstract… |
| |
|
|
|
| |
| AAOS Now
Orthopaedic Surgeons and Congressional Leaders Collaborate at the National Orthopaedic Leadership Conference
In this edition of Advocacy 201, AAOS Advocacy Council Chair Douglas W. Lundy, MD, MBA, FAAOS, addressed the AAOS National Orthopaedic Leadership Conference (NOLC), the main forum for AAOS members to personally lobby Congress on behalf of the orthopaedic profession. “The combined NOLC and Fall Meeting is a vital event where our leaders assemble to conduct the work of AAOS through the Board of Councilors/Board of Specialty Societies, educate and consider critical issues affecting our profession, and unify to lobby Congress on issues of vital interest that affect our ability to care for patients,” Dr. Lundy wrote.
Read more… |
| |
|
|
|
| |
| Your AAOS
Help Protect Access to Care and Reimbursement in 2023
The entire physician community is scheduled to face a 4.47 percent Medicare payment reduction starting Jan. 1, 2023, as a result of a recently finalized regulatory rule. The impending cut continues to generate significant instability for practices moving forward, threatening patients’ timely access to essential healthcare services. Congress can provide protection for patient services by passing legislation to provide relief from these cuts, and AAOS sent a letter this week urging for their inclusion in year-end legislation. You can support these advocacy efforts by sending a prewritten letter to your representatives today via the Advocacy Action Center.
Read AAOS’ letter to Congress…
Send a letter to your representative… |
| |
|
